From Reactive to Proactive: How Claremedica Rebuilt Its Approach to Dementia Detection in a Full-Risk Model
This complimentary webinar is brought to you by
The dementia wave is not coming — it is already here. With millions of Medicare Advantage members carrying undiagnosed cognitive conditions, every month of delayed detection compounds clinical harm, distorts risk accuracy, and drives avoidable cost deeper into full-risk contracts. Traditional screening approaches can’t keep up with the rising prevalence, increasing documentation requirements, and shrinking margins. Organizations that continue to rely on them are falling further behind with every patient encounter that passes without a structured cognitive assessment. Claremedica recognized this urgency and made a deliberate, strategic decision to prioritize dementia assessment — pivoting away from conventional detection methods and implementing a digital cognitive assessment solution before the gap became unmanageable. This webinar pulls back the curtain on that decision: why the status quo was no longer defensible, how Claremedica built and executed the case for change across clinical and financial stakeholders, and what other full-risk-bearing organizations need to understand right now about the cost of inaction on cognitive health.
Topics at a Glance
- Why delayed cognitive diagnosis is a compounding clinical and financial risk for full-risk Medicare Advantage organizations.
- What digital cognitive assessment is and why traditional screening methods can no longer keep pace.
- How Claremedica built the urgency case internally and drove alignment across clinical, operational, and financial stakeholders.
- What changed on the ground for clinicians and patients after the shift to structured cognitive screening.
- Reflections on early outcomes, and what full-risk leaders should be doing differently starting now.
Who Should Attend
-
CEO, CMO, and C-Suite Leaders at Value-Based Care Organizations
-
Medicare Advantage Plan Medical and Clinical Strategy Leaders
-
Population Health and Care Transformation Executives
-
Primary Care Group Leaders Operating in Full-Risk Arrangements
-
Health System and ACO Leaders Evaluating Cognitive Health Program Design
Top Reasons to Attend
- Understand why the window for proactive action on dementia detection is narrowing — and what it will cost to wait.
- Learn how Claremedica recognized the limits of traditional screening before they became a crisis and built a plan to address them.
- Explore the clinical, operational, and financial framework Claremedica used to evaluate, select, and implement digital cognitive assessment at scale.
- Benchmark your organization's current cognitive health approach against a proven full-risk model operating in today's environment.
- Leave with a concrete change management roadmap your team can act on immediately — not in the next planning cycle.
